In the past decades, the striking development of cationic polypeptides and cell-penetrating
peptides (CPPs) tailored for small interfering RNA (siRNA) delivery has been fuelled by the …

Gene therapy has emerged as a promising tool for treating different intractable diseases,
particularly cancer or even viral diseases such as COVID‐19 (coronavirus disease 2019). In …

Uterine leiomyoma (UL) is a prevalent benign tumor in women that frequently gives rise to a
multitude of reproductive complications. The use of suicide gene therapy has been …

Suicide gene therapy was suggested as a possible strategy for the treatment of uterine
fibroids (UFs), which are the most common benign tumors inwomen of reproductive age. For …

Water insolubility poses a significant challenge in the clinical applications of many small
molecule drugs. To improve the drug delivery efficiency, two branched amphiphilic peptides …

Uterine leiomyoma is the most common benign tumor of the reproductive system. Current
therapeutic options do not simultaneously meet the requirements of long-term efficiency and …

Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the
treatment of endometriosis (EM), which is the most common gynecological disease …

Breast cancer, the most prevalent female carcinoma, is characterized by the expression of
steroid nuclear receptors in a subset of cases. The most important nuclear receptor with …

The effective delivery of nucleic acid therapeutics into tumor cells is of great importance in
terms of cancer gene therapy. Successful application of siRNAs is restricted by the …

Uterine leiomyoma (UL) is one of the most common benign tumors in women that often
leads to many reproductive complications. Suicide genetherapy was suggested as a …